Process View
155 genes annotated in human
DOID:2914
A disease of anatomical entity that is located in the immune system.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "immune system disease"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
FANCD2 | Fanconi anemia, complementation group D2 | 1.000 | ||
FANCG | Fanconi anemia, complementation group G | 1.000 | ||
NCF1 | neutrophil cytosolic factor 1 | 1.000 | ||
C3 | complement component 3 | 1.000 | ||
FANCA | Fanconi anemia, complementation group A | 1.000 | ||
FGA | fibrinogen alpha chain | 1.000 | ||
BRCA2 | breast cancer 2, early onset | 1.000 | ||
FANCE | Fanconi anemia, complementation group E | 1.000 | ||
ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 1.000 | ||
FGB | fibrinogen beta chain | 1.000 | ||
BRCA1 | breast cancer 1, early onset | 1.000 | ||
CFH | complement factor H | 1.000 | ||
SPTB | spectrin, beta, erythrocytic | 1.000 | ||
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 1.000 | Human | |
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 1.000 | Human | |
NCF4 | neutrophil cytosolic factor 4, 40kDa | 1.000 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 1.000 | ||
REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.999 | Human | |
FANCB | Fanconi anemia, complementation group B | 0.998 | ||
ANK1 | ankyrin 1, erythrocytic | 0.998 | ||
FASLG | Fas ligand (TNF superfamily, member 6) | 0.998 | ||
FANCM | Fanconi anemia, complementation group M | 0.998 | ||
FANCL | Fanconi anemia, complementation group L | 0.998 | ||
HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.997 | Human | |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.995 | ||
SYK | spleen tyrosine kinase | 0.994 | ||
FGG | fibrinogen gamma chain | 0.994 | ||
OBSCN | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | 0.992 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.992 | Human | |
CD79A | CD79a molecule, immunoglobulin-associated alpha | 0.991 | ||
HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.991 | Human | |
FANCF | Fanconi anemia, complementation group F | 0.989 | ||
TAP2 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | 0.988 | ||
CYBA | cytochrome b-245, alpha polypeptide | 0.987 | ||
RPS25 | ribosomal protein S25 | 0.985 | ||
RAD51 | RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) | 0.985 | ||
TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.984 | ||
SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.982 | ||
HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.981 | ||
RHAG | Rh-associated glycoprotein | 0.979 | ||
MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0.974 | ||
BLM | Bloom syndrome, RecQ helicase-like | 0.973 | ||
RPS11 | ribosomal protein S11 | 0.971 | ||
NCF2 | neutrophil cytosolic factor 2 | 0.971 | ||
HLA-DMB | major histocompatibility complex, class II, DM beta | 0.969 | ||
TAPBP | TAP binding protein (tapasin) | 0.968 | ||
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.961 | ||
RPS16 | ribosomal protein S16 | 0.960 | ||
TLN1 | talin 1 | 0.954 | ||
RPLP2 | ribosomal protein, large, P2 | 0.952 | ||
CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.951 | ||
RPS10 | ribosomal protein S10 | 0.951 | ||
GP1BA | glycoprotein Ib (platelet), alpha polypeptide | 0.941 | ||
RPL38 | ribosomal protein L38 | 0.933 | ||
BLNK | B-cell linker | 0.933 | ||
LAT | linker for activation of T cells | 0.932 | ||
BTK | Bruton agammaglobulinemia tyrosine kinase | 0.931 | ||
RPS15A | ribosomal protein S15a | 0.929 | ||
RPL27 | ribosomal protein L27 | 0.922 | ||
EPB42 | erythrocyte membrane protein band 4.2 | 0.920 | ||
CD19 | CD19 molecule | 0.913 | ||
APLF | aprataxin and PNKP like factor | 0.902 | ||
TPI1 | triosephosphate isomerase 1 | 0.892 | ||
SPTA1 | spectrin, alpha, erythrocytic 1 (elliptocytosis 2) | 0.889 | ||
PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.881 | ||
RAD50 | RAD50 homolog (S. cerevisiae) | 0.880 | ||
FAS | Fas (TNF receptor superfamily, member 6) | 0.870 | ||
HP | haptoglobin | 0.866 | ||
C1S | complement component 1, s subcomponent | 0.864 | ||
RPS21 | ribosomal protein S21 | 0.863 | ||
RPS29 | ribosomal protein S29 | 0.862 | ||
MLH1 | mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) | 0.859 | ||
RPS14 | ribosomal protein S14 | 0.856 | ||
FADD | Fas (TNFRSF6)-associated via death domain | 0.850 | ||
GRB2 | growth factor receptor-bound protein 2 | 0.849 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.846 | Human | |
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.838 | ||
CD86 | CD86 molecule | 0.834 | Human | |
ALB | albumin | 0.827 | ||
KLF1 | Kruppel-like factor 1 (erythroid) | 0.816 | ||
CD80 | CD80 molecule | 0.804 | ||
PRKCB | protein kinase C, beta | 0.793 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.791 | ||
RPS13 | ribosomal protein S13 | 0.789 | ||
FANCC | Fanconi anemia, complementation group C | 0.788 | ||
LCK | lymphocyte-specific protein tyrosine kinase | 0.784 | Human | |
CFI | complement factor I | 0.784 | ||
APITD1 | apoptosis-inducing, TAF9-like domain 1 | 0.781 | ||
HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.781 | Human | |
MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.779 | ||
RPS15 | ribosomal protein S15 | 0.775 | ||
CD22 | CD22 molecule | 0.761 | ||
PSMB9 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) | 0.760 | ||
SLX4 | SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae) | 0.749 | ||
RAD18 | RAD18 homolog (S. cerevisiae) | 0.748 | ||
PMS2 | PMS2 postmeiotic segregation increased 2 (S. cerevisiae) | 0.745 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.743 | Human | |
SLX1B | SLX1 structure-specific endonuclease subunit homolog B (S. cerevisiae) | 0.741 | ||
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.740 | ||
XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | 0.737 | ||
RBBP8 | retinoblastoma binding protein 8 | 0.711 | ||
RPS28 | ribosomal protein S28 | 0.710 | ||
RPL35 | ribosomal protein L35 | 0.704 | ||
DMC1 | DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) | 0.692 | ||
RPS12 | ribosomal protein S12 | 0.691 | ||
RPS19 | ribosomal protein S19 | 0.685 | ||
PYCARD | PYD and CARD domain containing | 0.668 | ||
CFHR1 | complement factor H-related 1 | 0.667 | ||
RPS27 | ribosomal protein S27 | 0.661 | ||
RPS23 | ribosomal protein S23 | 0.655 | ||
SPTAN1 | spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) | 0.651 | Human | |
RAD51L3 | RAD51-like 3 (S. cerevisiae) | 0.631 | ||
RPL39 | ribosomal protein L39 | 0.630 | ||
HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.620 | ||
RPL9 | ribosomal protein L9 | 0.614 | ||
RPL23A | ribosomal protein L23a | 0.613 | ||
RPS7 | ribosomal protein S7 | 0.611 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.611 | ||
HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.601 | ||
MUS81 | MUS81 endonuclease homolog (S. cerevisiae) | 0.598 | ||
PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) | 0.588 | ||
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.587 | ||
PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.585 | ||
RPS24 | ribosomal protein S24 | 0.575 | ||
CD79B | CD79b molecule, immunoglobulin-associated beta | 0.574 | ||
GATA1 | GATA binding protein 1 (globin transcription factor 1) | 0.573 | ||
TRIM9 | tripartite motif containing 9 | 0.562 | ||
RPL6 | ribosomal protein L6 | 0.551 | ||
SBNO2 | strawberry notch homolog 2 (Drosophila) | 0.531 | ||
C19orf39 | chromosome 19 open reading frame 39 | 0.531 | ||
ZAP70 | zeta-chain (TCR) associated protein kinase 70kDa | 0.518 | ||
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.511 | Human | |
SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.510 | ||
C1R | complement component 1, r subcomponent | 0.499 | ||
CD247 | CD247 molecule | 0.497 | ||
F2 | coagulation factor II (thrombin) | 0.493 | ||
RPS8 | ribosomal protein S8 | 0.488 | ||
RAD51L1 | RAD51-like 1 (S. cerevisiae) | 0.483 | ||
WIPF1 | WAS/WASL interacting protein family, member 1 | 0.480 | ||
CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.480 | ||
RPL11 | ribosomal protein L11 | 0.472 | ||
HSPD1 | heat shock 60kDa protein 1 (chaperonin) | 0.472 | ||
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.472 | ||
NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.468 | ||
APOA1 | apolipoprotein A-I | 0.468 | Human | |
TCL1A | T-cell leukemia/lymphoma 1A | 0.467 | ||
ANXA4 | annexin A4 | 0.464 | ||
CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.459 | ||
RAD51AP1 | RAD51 associated protein 1 | 0.438 | ||
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.436 | Human | |
EME1 | essential meiotic endonuclease 1 homolog 1 (S. pombe) | 0.430 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.421 | ||
SNAP23 | synaptosomal-associated protein, 23kDa | 0.417 | ||
RPS6 | ribosomal protein S6 | 0.415 | ||
EPOR | erythropoietin receptor | 0.406 | ||
PPIF | peptidylprolyl isomerase F | 0.403 | ||
RPL37A | ribosomal protein L37a | 0.398 | ||
BARD1 | BRCA1 associated RING domain 1 | 0.394 | ||
RPS18 | ribosomal protein S18 | 0.392 | ||
CD9 | CD9 molecule | 0.386 | Human | |
CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.386 | ||
WASL | Wiskott-Aldrich syndrome-like | 0.382 | Human | |
ALAS2 | aminolevulinate, delta-, synthase 2 | 0.380 | ||
IPO4 | importin 4 | 0.379 | ||
MYL4 | myosin, light chain 4, alkali; atrial, embryonic | 0.378 | ||
RPL30 | ribosomal protein L30 | 0.378 | ||
A2M | alpha-2-macroglobulin | 0.372 | Human | |
KITLG | KIT ligand | 0.372 | ||
CD27 | CD27 molecule | 0.372 | ||
PRKCD | protein kinase C, delta | 0.372 | ||
ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.371 | ||
IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.369 | ||
RPS3 | ribosomal protein S3 | 0.352 | ||
FANCI | Fanconi anemia, complementation group I | 0.351 | ||
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.342 | ||
IGL@ | immunoglobulin lambda locus | 0.340 | ||
ERCC4 | excision repair cross-complementing rodent repair deficiency, complementation group 4 | 0.333 | ||
EEF1B2 | eukaryotic translation elongation factor 1 beta 2 | 0.324 | ||
C20orf94 | chromosome 20 open reading frame 94 | 0.324 | ||
RPL31 | ribosomal protein L31 | 0.322 | ||
RPS4X | ribosomal protein S4, X-linked | 0.318 | ||
RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.317 | ||
TNIP2 | TNFAIP3 interacting protein 2 | 0.313 | ||
IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.313 | ||
RPL19 | ribosomal protein L19 | 0.312 | ||
ERCC1 | excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) | 0.301 | ||
GYPB | glycophorin B (MNS blood group) | 0.301 | ||
RPL24 | ribosomal protein L24 | 0.299 | ||
MDC1 | mediator of DNA-damage checkpoint 1 | 0.297 | ||
XRCC3 | X-ray repair complementing defective repair in Chinese hamster cells 3 | 0.290 | ||
GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.288 | ||
GSPT1 | G1 to S phase transition 1 | 0.287 | ||
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.286 | Human | |
LRRC41 | leucine rich repeat containing 41 | 0.283 | ||
GRB7 | growth factor receptor-bound protein 7 | 0.283 | ||
CD72 | CD72 molecule | 0.280 | ||
C17orf70 | chromosome 17 open reading frame 70 | 0.276 | ||
ALDOA | aldolase A, fructose-bisphosphate | 0.275 | ||
GP9 | glycoprotein IX (platelet) | 0.273 | ||
PRTN3 | proteinase 3 | 0.272 | Human | |
RPS27A | ribosomal protein S27a | 0.269 | ||
INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.269 | ||
MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.267 | ||
APOC1 | apolipoprotein C-I | 0.266 | ||
IFNGR1 | interferon gamma receptor 1 | 0.266 | ||
ATM | ataxia telangiectasia mutated | 0.266 | ||
RPL34 | ribosomal protein L34 | 0.266 | ||
CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.265 | ||
PGLYRP1 | peptidoglycan recognition protein 1 | 0.262 | ||
PRKCA | protein kinase C, alpha | 0.259 | ||
ATAD2 | ATPase family, AAA domain containing 2 | 0.257 | ||
TSPAN4 | tetraspanin 4 | 0.257 | ||
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.251 | ||
FAU | Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed | 0.246 | ||
LDHA | lactate dehydrogenase A | 0.238 | ||
TOP3A | topoisomerase (DNA) III alpha | 0.236 | ||
GAB2 | GRB2-associated binding protein 2 | 0.230 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.225 | ||
PTPRC | protein tyrosine phosphatase, receptor type, C | 0.224 | ||
ACTB | actin, beta | 0.220 | ||
ITK | IL2-inducible T-cell kinase | 0.220 | ||
ASF1B | ASF1 anti-silencing function 1 homolog B (S. cerevisiae) | 0.217 | ||
CHAF1B | chromatin assembly factor 1, subunit B (p60) | 0.217 | ||
PF4 | platelet factor 4 | 0.216 | ||
CIITA | class II, major histocompatibility complex, transactivator | 0.214 | ||
MZB1 | marginal zone B and B1 cell-specific protein | 0.213 | ||
CD6 | CD6 molecule | 0.211 | ||
INSR | insulin receptor | 0.210 | ||
APTX | aprataxin | 0.209 | ||
MSH2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) | 0.208 | ||
PRKCQ | protein kinase C, theta | 0.208 | Human | |
LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.204 | ||
CLEC4M | C-type lectin domain family 4, member M | 0.202 | ||
CD2 | CD2 molecule | 0.200 | ||
KEL | Kell blood group, metallo-endopeptidase | 0.199 | ||
KLRK1 | killer cell lectin-like receptor subfamily K, member 1 | 0.198 | ||
MLF1IP | MLF1 interacting protein | 0.196 | ||
CCNE2 | cyclin E2 | 0.195 | ||
CFHR2 | complement factor H-related 2 | 0.187 | Human | |
RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.187 | ||
CA1 | carbonic anhydrase I | 0.187 | ||
PALB2 | partner and localizer of BRCA2 | 0.185 | ||
GATA2 | GATA binding protein 2 | 0.185 | Human | |
HLA-A | major histocompatibility complex, class I, A | 0.184 | ||
POU2AF1 | POU class 2 associating factor 1 | 0.184 | ||
NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 0.184 | ||
CD52 | CD52 molecule | 0.183 | ||
CASK | calcium/calmodulin-dependent serine protein kinase (MAGUK family) | 0.182 | ||
TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b | 0.182 | ||
GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.182 | ||
BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | 0.181 | ||
CAMP | cathelicidin antimicrobial peptide | 0.178 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.178 | ||
GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.178 | ||
GHR | growth hormone receptor | 0.178 | ||
VPREB3 | pre-B lymphocyte 3 | 0.176 | ||
IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.176 | ||
THBS1 | thrombospondin 1 | 0.176 | ||
RPL35A | ribosomal protein L35a | 0.174 | ||
TERF2 | telomeric repeat binding factor 2 | 0.174 | ||
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.173 | ||
IGJ | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | 0.172 | ||
DUSP23 | dual specificity phosphatase 23 | 0.170 | ||
UBA52 | ubiquitin A-52 residue ribosomal protein fusion product 1 | 0.167 | ||
RPS20 | ribosomal protein S20 | 0.166 | ||
MPO | myeloperoxidase | 0.165 | ||
RPL17 | ribosomal protein L17 | 0.164 | ||
GPR171 | G protein-coupled receptor 171 | 0.164 | ||
CENPK | centromere protein K | 0.161 | ||
BLK | B lymphoid tyrosine kinase | 0.161 | Human | |
ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | 0.160 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.160 | ||
WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.159 | ||
PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.159 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.159 | ||
BCR | breakpoint cluster region | 0.158 | ||
NFE2 | nuclear factor (erythroid-derived 2), 45kDa | 0.156 | ||
HBZ | hemoglobin, zeta | 0.155 | ||
JAK3 | Janus kinase 3 | 0.155 | Human | |
DNA2 | DNA replication helicase 2 homolog (yeast) | 0.154 | ||
DEFA4 | defensin, alpha 4, corticostatin | 0.152 | ||
MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.148 | ||
IRF8 | interferon regulatory factor 8 | 0.146 | Human | |
CDCP1 | CUB domain containing protein 1 | 0.146 | ||
AHSG | alpha-2-HS-glycoprotein | 0.145 | ||
VWF | von Willebrand factor | 0.142 | ||
CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.141 | Human | |
CTSW | cathepsin W | 0.139 | ||
LTK | leukocyte receptor tyrosine kinase | 0.139 | ||
TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.138 | Human | |
CAPG | capping protein (actin filament), gelsolin-like | 0.138 | ||
INO80B | INO80 complex subunit B | 0.138 | ||
IL4R | interleukin 4 receptor | 0.137 | ||
NBN | nibrin | 0.136 | ||
TRIM10 | tripartite motif containing 10 | 0.134 | ||
RPL23 | ribosomal protein L23 | 0.133 | ||
CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.132 | ||
CD164 | CD164 molecule, sialomucin | 0.132 | ||
TAF6L | TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa | 0.131 | ||
CD28 | CD28 molecule | 0.130 | Human | |
IRF4 | interferon regulatory factor 4 | 0.130 | ||
CFB | complement factor B | 0.129 | ||
GZMK | granzyme K (granzyme 3; tryptase II) | 0.128 | ||
GTF2I | general transcription factor IIi | 0.128 | ||
MSH6 | mutS homolog 6 (E. coli) | 0.127 | ||
FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.127 | Human | |
LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.126 | ||
PCNA | proliferating cell nuclear antigen | 0.125 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.123 | ||
MSH3 | mutS homolog 3 (E. coli) | 0.123 | ||
POLH | polymerase (DNA directed), eta | 0.123 | ||
CENPQ | centromere protein Q | 0.123 | ||
PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.121 | ||
PNOC | prepronociceptin | 0.120 | ||
SH2D2A | SH2 domain containing 2A | 0.120 | ||
ACACA | acetyl-CoA carboxylase alpha | 0.119 | ||
SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.119 | ||
GOT1 | glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) | 0.119 | ||
PDCD4 | programmed cell death 4 (neoplastic transformation inhibitor) | 0.118 | ||
DSN1 | DSN1, MIND kinetochore complex component, homolog (S. cerevisiae) | 0.117 | ||
PPA1 | pyrophosphatase (inorganic) 1 | 0.117 | ||
SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | 0.116 | ||
CNR2 | cannabinoid receptor 2 (macrophage) | 0.115 | ||
NDUFS1 | NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) | 0.114 | ||
HLA-F | major histocompatibility complex, class I, F | 0.113 | ||
GEN1 | Gen homolog 1, endonuclease (Drosophila) | 0.112 | ||
RPS2 | ribosomal protein S2 | 0.111 | ||
CD5 | CD5 molecule | 0.110 | ||
LTF | lactotransferrin | 0.109 | ||
FAIM3 | Fas apoptotic inhibitory molecule 3 | 0.109 | ||
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.108 | ||
HRG | histidine-rich glycoprotein | 0.108 | ||
HIPK2 | homeodomain interacting protein kinase 2 | 0.108 | ||
VKORC1 | vitamin K epoxide reductase complex, subunit 1 | 0.108 | ||
AHSP | alpha hemoglobin stabilizing protein | 0.108 | ||
LY86 | lymphocyte antigen 86 | 0.107 | ||
NTN3 | netrin 3 | 0.107 | ||
SEC24D | SEC24 family, member D (S. cerevisiae) | 0.107 | ||
KIAA1539 | KIAA1539 | 0.107 | ||
CD1C | CD1c molecule | 0.106 | ||
MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.106 | ||
GAS7 | growth arrest-specific 7 | 0.106 | ||
CENPJ | centromere protein J | 0.106 | ||
HBD | hemoglobin, delta | 0.105 | ||
PLTP | phospholipid transfer protein | 0.105 | ||
SYCP3 | synaptonemal complex protein 3 | 0.105 | ||
GNLY | granulysin | 0.104 | ||
PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 0.104 | ||
CTSH | cathepsin H | 0.104 | ||
GPNMB | glycoprotein (transmembrane) nmb | 0.103 | ||
PTPN18 | protein tyrosine phosphatase, non-receptor type 18 (brain-derived) | 0.102 | Human | |
ARHGEF1 | Rho guanine nucleotide exchange factor (GEF) 1 | 0.101 | ||
RPS5 | ribosomal protein S5 | 0.101 | ||
IL32 | interleukin 32 | 0.101 | ||
ADD2 | adducin 2 (beta) | 0.100 | ||
KIAA0101 | KIAA0101 | 0.099 | ||
HDC | histidine decarboxylase | 0.098 | ||
MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.098 | ||
CPD | carboxypeptidase D | 0.097 | ||
H2AFX | H2A histone family, member X | 0.096 | ||
NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.096 | ||
TFR2 | transferrin receptor 2 | 0.095 | ||
GPR18 | G protein-coupled receptor 18 | 0.095 | ||
CD3D | CD3d molecule, delta (CD3-TCR complex) | 0.095 | ||
ZSCAN16 | zinc finger and SCAN domain containing 16 | 0.095 | ||
NUCB1 | nucleobindin 1 | 0.095 | ||
SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.094 | ||
STAP1 | signal transducing adaptor family member 1 | 0.094 | ||
RGS14 | regulator of G-protein signaling 14 | 0.093 | ||
RPA1 | replication protein A1, 70kDa | 0.093 | ||
RPS17 | ribosomal protein S17 | 0.093 | ||
RFX5 | regulatory factor X, 5 (influences HLA class II expression) | 0.092 | ||
CRP | C-reactive protein, pentraxin-related | 0.092 | ||
HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.092 | Human | |
JAK2 | Janus kinase 2 | 0.091 | ||
TTN | titin | 0.091 | ||
PRPS1 | phosphoribosyl pyrophosphate synthetase 1 | 0.090 | ||
FNBP1 | formin binding protein 1 | 0.090 | ||
APOC4 | apolipoprotein C-IV | 0.090 | ||
RPL14 | ribosomal protein L14 | 0.090 | ||
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.089 | ||
P2RY10 | purinergic receptor P2Y, G-protein coupled, 10 | 0.089 | ||
RPS3A | ribosomal protein S3A | 0.088 | ||
PSD4 | pleckstrin and Sec7 domain containing 4 | 0.088 | ||
EPX | eosinophil peroxidase | 0.088 | ||
F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.087 | Human | |
CETP | cholesteryl ester transfer protein, plasma | 0.086 | ||
ALG6 | asparagine-linked glycosylation 6, alpha-1,3-glucosyltransferase homolog (S. cerevisiae) | 0.085 | ||
TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.085 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.085 | ||
SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.084 | ||
ACO2 | aconitase 2, mitochondrial | 0.084 | ||
NEDD8 | neural precursor cell expressed, developmentally down-regulated 8 | 0.084 | ||
HLA-DOB | major histocompatibility complex, class II, DO beta | 0.083 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.083 | Human | |
APOC2 | apolipoprotein C-II | 0.083 | ||
XRCC2 | X-ray repair complementing defective repair in Chinese hamster cells 2 | 0.083 | ||
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | 0.083 | ||
IL2RA | interleukin 2 receptor, alpha | 0.083 | ||
LYL1 | lymphoblastic leukemia derived sequence 1 | 0.083 | ||
SHMT2 | serine hydroxymethyltransferase 2 (mitochondrial) | 0.082 | ||
CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.082 | ||
RIOK3 | RIO kinase 3 (yeast) | 0.082 | ||
B2M | beta-2-microglobulin | 0.082 | ||
CD37 | CD37 molecule | 0.082 | ||
CASP8AP2 | caspase 8 associated protein 2 | 0.082 | ||
ARG1 | arginase, liver | 0.082 | ||
GP6 | glycoprotein VI (platelet) | 0.082 | ||
SOCS3 | suppressor of cytokine signaling 3 | 0.082 | ||
RHD | Rh blood group, D antigen | 0.082 | Human | |
NCR3 | natural cytotoxicity triggering receptor 3 | 0.082 | ||
PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | 0.081 | ||
KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.081 | ||
VDAC1 | voltage-dependent anion channel 1 | 0.081 | ||
NCKAP1L | NCK-associated protein 1-like | 0.081 | ||
ICAM4 | intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) | 0.080 | ||
MPHOSPH9 | M-phase phosphoprotein 9 | 0.080 | ||
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.079 | ||
IL2RB | interleukin 2 receptor, beta | 0.079 | ||
HLA-G | major histocompatibility complex, class I, G | 0.079 | ||
SOS1 | son of sevenless homolog 1 (Drosophila) | 0.079 | ||
PDIA3 | protein disulfide isomerase family A, member 3 | 0.079 | ||
NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.078 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.078 | Human | |
CLEC1B | C-type lectin domain family 1, member B | 0.078 | ||
PLEK | pleckstrin | 0.078 | ||
HCK | hemopoietic cell kinase | 0.076 | Human | |
PVRIG | poliovirus receptor related immunoglobulin domain containing | 0.076 | ||
KNTC1 | kinetochore associated 1 | 0.076 | ||
CAPN1 | calpain 1, (mu/I) large subunit | 0.076 | ||
TERF2IP | telomeric repeat binding factor 2, interacting protein | 0.075 | ||
CCL5 | chemokine (C-C motif) ligand 5 | 0.075 | ||
FCRL2 | Fc receptor-like 2 | 0.075 | ||
CD38 | CD38 molecule | 0.074 | ||
MRC1 | mannose receptor, C type 1 | 0.074 | ||
CEACAM4 | carcinoembryonic antigen-related cell adhesion molecule 4 | 0.074 | ||
CTSG | cathepsin G | 0.073 | ||
MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.073 | ||
KRT8 | keratin 8 | 0.072 | ||
GFI1 | growth factor independent 1 transcription repressor | 0.072 | ||
TBXA2R | thromboxane A2 receptor | 0.072 | ||
CD3G | CD3g molecule, gamma (CD3-TCR complex) | 0.071 | ||
GM2A | GM2 ganglioside activator | 0.071 | ||
TBK1 | TANK-binding kinase 1 | 0.071 | ||
MPL | myeloproliferative leukemia virus oncogene | 0.070 | ||
CD7 | CD7 molecule | 0.070 | ||
TSPAN32 | tetraspanin 32 | 0.070 | ||
CD180 | CD180 molecule | 0.070 | Human | |
STAT4 | signal transducer and activator of transcription 4 | 0.070 | Human | |
HLA-DQA2 | major histocompatibility complex, class II, DQ alpha 2 | 0.069 | ||
CTSS | cathepsin S | 0.069 | ||
SKAP1 | src kinase associated phosphoprotein 1 | 0.069 | ||
CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.069 | ||
LAX1 | lymphocyte transmembrane adaptor 1 | 0.069 | ||
BSG | basigin (Ok blood group) | 0.069 | ||
HBG2 | hemoglobin, gamma G | 0.068 | ||
MMS22L | MMS22-like, DNA repair protein | 0.068 | ||
RHOH | ras homolog gene family, member H | 0.068 | ||
STK10 | serine/threonine kinase 10 | 0.068 | ||
GIMAP5 | GTPase, IMAP family member 5 | 0.067 | ||
LCN2 | lipocalin 2 | 0.067 | ||
NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.067 | ||
MS4A3 | membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) | 0.067 | ||
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.066 | ||
EBI3 | Epstein-Barr virus induced 3 | 0.066 | ||
NHEJ1 | nonhomologous end-joining factor 1 | 0.066 | ||
MAN2B1 | mannosidase, alpha, class 2B, member 1 | 0.066 | ||
CST7 | cystatin F (leukocystatin) | 0.066 | ||
IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.066 | ||
IL7R | interleukin 7 receptor | 0.066 | ||
AIFM1 | apoptosis-inducing factor, mitochondrion-associated, 1 | 0.065 | ||
PASK | PAS domain containing serine/threonine kinase | 0.065 | ||
RPL18 | ribosomal protein L18 | 0.065 | ||
GP5 | glycoprotein V (platelet) | 0.065 | ||
GCDH | glutaryl-CoA dehydrogenase | 0.065 | ||
SAP25 | sin3A-binding protein 25 | 0.065 | ||
GMIP | GEM interacting protein | 0.065 | ||
PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) | 0.065 | ||
NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.065 | ||
CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | 0.065 | ||
GPSM3 | G-protein signaling modulator 3 | 0.064 | ||
CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.064 | ||
VAV1 | vav 1 guanine nucleotide exchange factor | 0.064 | ||
GZMH | granzyme H (cathepsin G-like 2, protein h-CCPX) | 0.064 | ||
SPN | sialophorin | 0.064 | ||
RPL41 | ribosomal protein L41 | 0.064 | ||
TSPO2 | translocator protein 2 | 0.064 | ||
MAVS | mitochondrial antiviral signaling protein | 0.063 | ||
ANKRD32 | ankyrin repeat domain 32 | 0.063 | ||
BTN2A2 | butyrophilin, subfamily 2, member A2 | 0.063 | Human | |
GYPE | glycophorin E (MNS blood group) | 0.063 | ||
CD226 | CD226 molecule | 0.063 | ||
TNFSF13 | tumor necrosis factor (ligand) superfamily, member 13 | 0.063 | ||
PACSIN2 | protein kinase C and casein kinase substrate in neurons 2 | 0.063 | ||
SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.062 | ||
SAA4 | serum amyloid A4, constitutive | 0.062 | ||
GYS1 | glycogen synthase 1 (muscle) | 0.062 | ||
IGF1R | insulin-like growth factor 1 receptor | 0.062 | ||
RPLP1 | ribosomal protein, large, P1 | 0.062 | ||
TKT | transketolase | 0.062 | ||
RPS26 | ribosomal protein S26 | 0.062 | ||
AZU1 | azurocidin 1 | 0.061 | Human | |
TMX2 | thioredoxin-related transmembrane protein 2 | 0.061 | ||
BPI | bactericidal/permeability-increasing protein | 0.061 | ||
SASS6 | spindle assembly 6 homolog (C. elegans) | 0.061 | ||
TRIP10 | thyroid hormone receptor interactor 10 | 0.061 | ||
TREML2 | triggering receptor expressed on myeloid cells-like 2 | 0.061 | ||
CAPN2 | calpain 2, (m/II) large subunit | 0.060 | ||
TEC | tec protein tyrosine kinase | 0.060 | ||
TRAT1 | T cell receptor associated transmembrane adaptor 1 | 0.060 | ||
GZMA | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 0.060 | ||
TPT1 | tumor protein, translationally-controlled 1 | 0.060 | ||
AXL | AXL receptor tyrosine kinase | 0.059 | ||
FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | 0.059 | ||
NR5A1 | nuclear receptor subfamily 5, group A, member 1 | 0.058 | ||
SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene spi1 | 0.058 | ||
IRF1 | interferon regulatory factor 1 | 0.058 | Human | |
CSF1R | colony stimulating factor 1 receptor | 0.058 | Human | |
LY9 | lymphocyte antigen 9 | 0.058 | ||
JAK1 | Janus kinase 1 | 0.058 | Human | |
RPSA | ribosomal protein SA | 0.058 | ||
RAD52 | RAD52 homolog (S. cerevisiae) | 0.058 | ||
GP1BB | glycoprotein Ib (platelet), beta polypeptide | 0.057 | ||
C19orf50 | chromosome 19 open reading frame 50 | 0.057 | ||
SH3BP5 | SH3-domain binding protein 5 (BTK-associated) | 0.057 | ||
PLG | plasminogen | 0.057 | Human | |
RNF8 | ring finger protein 8 | 0.057 | ||
VPREB1 | pre-B lymphocyte 1 | 0.057 | ||
TNFRSF17 | tumor necrosis factor receptor superfamily, member 17 | 0.057 | ||
KNG1 | kininogen 1 | 0.057 | ||
MAP2 | microtubule-associated protein 2 | 0.057 | ||
ACTN4 | actinin, alpha 4 | 0.057 | ||
CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.057 | ||
CD93 | CD93 molecule | 0.056 | Human | |
SOS2 | son of sevenless homolog 2 (Drosophila) | 0.056 | ||
NOD1 | nucleotide-binding oligomerization domain containing 1 | 0.056 | Human | |
SHFM1 | split hand/foot malformation (ectrodactyly) type 1 | 0.056 | ||
FCRLA | Fc receptor-like A | 0.056 | Human | |
OSBP2 | oxysterol binding protein 2 | 0.056 | ||
GYPA | glycophorin A (MNS blood group) | 0.056 | ||
HELLS | helicase, lymphoid-specific | 0.055 | ||
BCL2 | B-cell CLL/lymphoma 2 | 0.055 | ||
ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.055 | ||
SCLT1 | sodium channel and clathrin linker 1 | 0.055 | ||
CD8A | CD8a molecule | 0.055 | ||
CD33 | CD33 molecule | 0.055 | ||
LIPC | lipase, hepatic | 0.055 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.054 | ||
FHL2 | four and a half LIM domains 2 | 0.054 | ||
DCLRE1A | DNA cross-link repair 1A | 0.054 | ||
KPNA1 | karyopherin alpha 1 (importin alpha 5) | 0.054 | ||
CTSE | cathepsin E | 0.054 | ||
SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.053 | ||
IL16 | interleukin 16 (lymphocyte chemoattractant factor) | 0.053 | ||
PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 | 0.053 | ||
OGFR | opioid growth factor receptor | 0.053 | ||
KIAA0748 | KIAA0748 | 0.053 | ||
TMEM194A | transmembrane protein 194A | 0.053 | ||
SENP8 | SUMO/sentrin specific peptidase family member 8 | 0.053 | ||
LAMC3 | laminin, gamma 3 | 0.053 | ||
PLK1 | polo-like kinase 1 | 0.053 | ||
APOA2 | apolipoprotein A-II | 0.053 | ||
CD36 | CD36 molecule (thrombospondin receptor) | 0.052 | ||
ZBTB16 | zinc finger and BTB domain containing 16 | 0.052 | ||
GOT2 | glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) | 0.052 | ||
FIGNL1 | fidgetin-like 1 | 0.052 | ||
CARD11 | caspase recruitment domain family, member 11 | 0.052 | ||
STAT5B | signal transducer and activator of transcription 5B | 0.052 | Human | |
MXD1 | MAX dimerization protein 1 | 0.052 | ||
C5orf34 | chromosome 5 open reading frame 34 | 0.052 | ||
RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.051 | ||
FBXO32 | F-box protein 32 | 0.051 | ||
TRAF5 | TNF receptor-associated factor 5 | 0.051 | ||
GCKR | glucokinase (hexokinase 4) regulator | 0.051 | ||
ZWILCH | Zwilch, kinetochore associated, homolog (Drosophila) | 0.051 | ||
FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | 0.051 | ||
PDZK1IP1 | PDZK1 interacting protein 1 | 0.051 | ||
PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.051 | ||
TYK2 | tyrosine kinase 2 | 0.051 | Human | |
DDOST | dolichyl-diphosphooligosaccharide--protein glycosyltransferase | 0.051 | ||
TAPBPL | TAP binding protein-like | 0.051 | ||
NOP58 | NOP58 ribonucleoprotein homolog (yeast) | 0.051 | ||
CR2 | complement component (3d/Epstein Barr virus) receptor 2 | 0.051 | ||
GLA | galactosidase, alpha | 0.051 | ||
CPA3 | carboxypeptidase A3 (mast cell) | 0.050 | ||
LRMP | lymphoid-restricted membrane protein | 0.050 | ||
SLA2 | Src-like-adaptor 2 | 0.050 | ||
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | 0.050 | ||
NNMT | nicotinamide N-methyltransferase | 0.050 | ||
INTS7 | integrator complex subunit 7 | 0.050 | ||
WDHD1 | WD repeat and HMG-box DNA binding protein 1 | 0.050 | ||
PTPRCAP | protein tyrosine phosphatase, receptor type, C-associated protein | 0.050 | ||
DNTT | deoxynucleotidyltransferase, terminal | 0.050 | ||
MPV17 | MpV17 mitochondrial inner membrane protein | 0.050 | ||
MBD4 | methyl-CpG binding domain protein 4 | 0.049 | ||
NLRC4 | NLR family, CARD domain containing 4 | 0.049 | ||
KLRG1 | killer cell lectin-like receptor subfamily G, member 1 | 0.049 | ||
PRG2 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | 0.049 | ||
KCNA3 | potassium voltage-gated channel, shaker-related subfamily, member 3 | 0.049 | ||
FCRL3 | Fc receptor-like 3 | 0.049 | ||
CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.049 | ||
EPB49 | erythrocyte membrane protein band 4.9 (dematin) | 0.049 | ||
RPS9 | ribosomal protein S9 | 0.049 | ||
RBL1 | retinoblastoma-like 1 (p107) | 0.049 | ||
CD63 | CD63 molecule | 0.049 | ||
ORM1 | orosomucoid 1 | 0.048 | ||
SIGLEC7 | sialic acid binding Ig-like lectin 7 | 0.048 | ||
APCS | amyloid P component, serum | 0.048 | ||
CD40LG | CD40 ligand | 0.048 | ||
HLA-DQB2 | major histocompatibility complex, class II, DQ beta 2 | 0.048 | ||
BRCC3 | BRCA1/BRCA2-containing complex, subunit 3 | 0.048 | ||
ITGB7 | integrin, beta 7 | 0.048 | ||
FN1 | fibronectin 1 | 0.048 | ||
FMNL1 | formin-like 1 | 0.048 | ||
CST3 | cystatin C | 0.048 | ||
MMRN1 | multimerin 1 | 0.048 | ||
PAX5 | paired box 5 | 0.048 | ||
TTF2 | transcription termination factor, RNA polymerase II | 0.048 | ||
SELL | selectin L | 0.048 | ||
PYHIN1 | pyrin and HIN domain family, member 1 | 0.048 | ||
CD4 | CD4 molecule | 0.048 | ||
RPL36A | ribosomal protein L36a | 0.048 | ||
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | 0.047 | ||
PF4V1 | platelet factor 4 variant 1 | 0.047 | ||
CCDC72 | coiled-coil domain containing 72 | 0.047 | ||
TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.047 | ||
SMC2 | structural maintenance of chromosomes 2 | 0.047 | ||
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.047 | ||
MNS1 | meiosis-specific nuclear structural 1 | 0.047 | ||
UIMC1 | ubiquitin interaction motif containing 1 | 0.046 | ||
CD274 | CD274 molecule | 0.046 | Human | |
C8A | complement component 8, alpha polypeptide | 0.046 | ||
RPL27A | ribosomal protein L27a | 0.046 | ||
F5 | coagulation factor V (proaccelerin, labile factor) | 0.046 | ||
CD96 | CD96 molecule | 0.046 | ||
PILRA | paired immunoglobin-like type 2 receptor alpha | 0.046 | ||
IDH1 | isocitrate dehydrogenase 1 (NADP+), soluble | 0.046 | ||
RARRES1 | retinoic acid receptor responder (tazarotene induced) 1 | 0.046 | ||
HTRA1 | HtrA serine peptidase 1 | 0.046 | ||
KRT1 | keratin 1 | 0.046 | ||
GRN | granulin | 0.046 | ||
PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0.046 | ||
HEMGN | hemogen | 0.046 | ||
EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.045 | ||
ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.045 | Human | |
CABP5 | calcium binding protein 5 | 0.045 | ||
RMI1 | RMI1, RecQ mediated genome instability 1, homolog (S. cerevisiae) | 0.045 | ||
GRPEL1 | GrpE-like 1, mitochondrial (E. coli) | 0.045 | ||
APOB | apolipoprotein B (including Ag(x) antigen) | 0.045 | ||
TXK | TXK tyrosine kinase | 0.045 | Human | |
SRPX | sushi-repeat containing protein, X-linked | 0.045 | ||
TREML1 | triggering receptor expressed on myeloid cells-like 1 | 0.045 | ||
GPR97 | G protein-coupled receptor 97 | 0.045 | ||
CHID1 | chitinase domain containing 1 | 0.045 | ||
MS4A6A | membrane-spanning 4-domains, subfamily A, member 6A | 0.044 | ||
SDC2 | syndecan 2 | 0.044 | ||
APOA4 | apolipoprotein A-IV | 0.044 | ||
FLT4 | fms-related tyrosine kinase 4 | 0.044 | ||
CCR9 | chemokine (C-C motif) receptor 9 | 0.044 | ||
GYPC | glycophorin C (Gerbich blood group) | 0.044 | ||
S100A12 | S100 calcium binding protein A12 | 0.044 | ||
DOK3 | docking protein 3 | 0.044 | ||
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | 0.044 | ||
CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.044 | ||
IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.044 | ||
RPL28 | ribosomal protein L28 | 0.044 | ||
RHBDF2 | rhomboid 5 homolog 2 (Drosophila) | 0.044 | ||
SPP2 | secreted phosphoprotein 2, 24kDa | 0.044 | ||
PKLR | pyruvate kinase, liver and RBC | 0.044 | ||
GTPBP1 | GTP binding protein 1 | 0.044 | ||
EXO1 | exonuclease 1 | 0.043 | ||
COX7B | cytochrome c oxidase subunit VIIb | 0.043 | ||
FCRL1 | Fc receptor-like 1 | 0.043 | ||
STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.043 | Human | |
GFI1B | growth factor independent 1B transcription repressor | 0.043 | Human | |
PTPN7 | protein tyrosine phosphatase, non-receptor type 7 | 0.043 | ||
HBE1 | hemoglobin, epsilon 1 | 0.043 | ||
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.043 | ||
CP | ceruloplasmin (ferroxidase) | 0.043 | Human | |
HMMR | hyaluronan-mediated motility receptor (RHAMM) | 0.043 | ||
HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.043 | ||
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.043 | ||
TNIP1 | TNFAIP3 interacting protein 1 | 0.043 | ||
SLC25A40 | solute carrier family 25, member 40 | 0.043 | ||
FGL1 | fibrinogen-like 1 | 0.043 | Human | |
NEK6 | NIMA (never in mitosis gene a)-related kinase 6 | 0.043 | ||
RPL29 | ribosomal protein L29 | 0.042 | ||
ERMP1 | endoplasmic reticulum metallopeptidase 1 | 0.042 | ||
TMSB4Y | thymosin beta 4, Y-linked | 0.042 | ||
IL7 | interleukin 7 | 0.042 | ||
RAD51C | RAD51 homolog C (S. cerevisiae) | 0.042 | ||
IGLL5 | immunoglobulin lambda-like polypeptide 5 | 0.042 | ||
CEP152 | centrosomal protein 152kDa | 0.042 | ||
TRAF1 | TNF receptor-associated factor 1 | 0.042 | ||
RPL7 | ribosomal protein L7 | 0.042 | ||
PNKP | polynucleotide kinase 3'-phosphatase | 0.042 | ||
BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0.042 | ||
SIRPA | signal-regulatory protein alpha | 0.042 | ||
SIRPG | signal-regulatory protein gamma | 0.042 | ||
ADAM28 | ADAM metallopeptidase domain 28 | 0.042 | ||
EPB41 | erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) | 0.042 | ||
RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | 0.042 | ||
SERPIND1 | serpin peptidase inhibitor, clade D (heparin cofactor), member 1 | 0.042 | ||
SEMA7A | semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) | 0.042 | ||
P2RX5 | purinergic receptor P2X, ligand-gated ion channel, 5 | 0.042 | ||
LIN7A | lin-7 homolog A (C. elegans) | 0.042 | ||
HCP5 | HLA complex P5 | 0.042 | ||
ZNF367 | zinc finger protein 367 | 0.042 | ||
CD5L | CD5 molecule-like | 0.041 | ||
ZDHHC24 | zinc finger, DHHC-type containing 24 | 0.041 | ||
TAF9 | TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa | 0.041 | ||
BRAP | BRCA1 associated protein | 0.041 | ||
F11 | coagulation factor XI | 0.041 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.041 | ||
HSPE1 | heat shock 10kDa protein 1 (chaperonin 10) | 0.041 | ||
SNX22 | sorting nexin 22 | 0.041 | ||
RHCE | Rh blood group, CcEe antigens | 0.041 | Human | |
STIL | SCL/TAL1 interrupting locus | 0.041 | ||
IL10 | interleukin 10 | 0.041 | ||
CD53 | CD53 molecule | 0.041 | ||
HBQ1 | hemoglobin, theta 1 | 0.041 | ||
VAV3 | vav 3 guanine nucleotide exchange factor | 0.041 | ||
LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.041 | ||
P2RY14 | purinergic receptor P2Y, G-protein coupled, 14 | 0.040 | ||
UBD | ubiquitin D | 0.040 | ||
IDH3A | isocitrate dehydrogenase 3 (NAD+) alpha | 0.040 | ||
GLB1 | galactosidase, beta 1 | 0.040 | ||
SARS | seryl-tRNA synthetase | 0.040 | ||
HLA-C | major histocompatibility complex, class I, C | 0.040 | ||
P2RX1 | purinergic receptor P2X, ligand-gated ion channel, 1 | 0.040 | ||
S1PR4 | sphingosine-1-phosphate receptor 4 | 0.040 | ||
SH2B1 | SH2B adaptor protein 1 | 0.040 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.040 | Human | |
LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.040 | ||
F13B | coagulation factor XIII, B polypeptide | 0.040 | ||
DCN | decorin | 0.040 | ||
CSTB | cystatin B (stefin B) | 0.040 | ||
SH3GL3 | SH3-domain GRB2-like 3 | 0.040 | ||
HAL | histidine ammonia-lyase | 0.040 | ||
ORM2 | orosomucoid 2 | 0.040 | ||
C8B | complement component 8, beta polypeptide | 0.040 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.040 | ||
RNASE3 | ribonuclease, RNase A family, 3 | 0.040 | ||
LILRA5 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 | 0.040 | ||
BCKDK | branched chain ketoacid dehydrogenase kinase | 0.040 | ||
NARS | asparaginyl-tRNA synthetase | 0.039 | ||
NKG7 | natural killer cell group 7 sequence | 0.039 | ||
CHUK | conserved helix-loop-helix ubiquitous kinase | 0.039 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.039 | Human | |
LDLR | low density lipoprotein receptor | 0.039 |